Quoin Pharmaceuticals Ltd. SEC filings QNRX

Quoin Pharmaceuticals Ltd. has 583 filings in SEC EDGAR's recent list, going back to Apr 8, 2016. Its latest annual report, Form ARS, was filed on Jul 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (material agreement).

Quoin Pharmaceuticals Ltd. SEC filings
Form Description Filed Period
4/A Ownership document Oct 26, 2026 Aug 27, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 7, 2026 —
4 Insider transaction Sep 1, 2026 Aug 31, 2026
4 Insider transaction Sep 1, 2026 Aug 31, 2026
4 Insider transaction Sep 1, 2026 Aug 31, 2026
4 Insider transaction Sep 1, 2026 Aug 31, 2026
4 Insider transaction Aug 28, 2026 Aug 27, 2026
4 Insider transaction Aug 28, 2026 Aug 27, 2026
SCHEDULE 13G Ownership over 5% (passive) Jun 2, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 29, 2026 —
4 Insider transaction Mar 31, 2026 Mar 26, 2026
SCHEDULE 13G Ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 11, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 6, 2026 —
4 Insider transaction Feb 6, 2026 Feb 4, 2026
4 Insider transaction Feb 6, 2026 Feb 4, 2026
4 Insider transaction Feb 6, 2026 Feb 4, 2026
4 Insider transaction Feb 6, 2026 Feb 4, 2026
4 Insider transaction Feb 6, 2026 Feb 4, 2026
4 Insider transaction Feb 6, 2026 Feb 4, 2026
4 Insider transaction Feb 6, 2026 Feb 4, 2026
4 Insider transaction Feb 6, 2026 Feb 4, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 2, 2026 —
3 Initial insider ownership Feb 2, 2026 Jan 29, 2026
SCHEDULE 13G Ownership over 5% (passive) Jan 28, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Dec 16, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Dec 15, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Dec 11, 2025 —
4 Insider transaction Dec 3, 2025 Dec 1, 2025
SCHEDULE 13G Ownership over 5% (passive) Oct 27, 2025 —
4 Insider transaction Oct 15, 2025 Oct 14, 2025
3 Initial insider ownership Sep 8, 2025 Aug 18, 2025
4 Insider transaction Aug 25, 2025 Aug 21, 2025
4 Insider transaction Aug 25, 2025 Aug 21, 2025
4 Insider transaction Aug 25, 2025 Aug 21, 2025
4/A Ownership document Jun 13, 2025 May 29, 2025
4/A Ownership document Jun 13, 2025 May 29, 2025
4 Insider transaction Jun 3, 2025 May 29, 2025
4 Insider transaction Jun 2, 2025 May 29, 2025
4 Insider transaction Jun 2, 2025 May 29, 2025
4 Insider transaction Jun 2, 2025 May 29, 2025
4 Insider transaction Jun 2, 2025 May 29, 2025
4 Insider transaction Jun 2, 2025 May 29, 2025
4 Insider transaction Jun 2, 2025 May 29, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Jan 28, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Jan 28, 2025 —
SCHEDULE 13D Ownership over 5% (active) Jan 2, 2025 —
SCHEDULE 13D Ownership over 5% (active) Jan 2, 2025 —
4 Insider transaction Dec 27, 2024 Dec 23, 2024
4 Insider transaction Dec 27, 2024 Dec 23, 2024
4 Insider transaction Dec 27, 2024 Dec 23, 2024
4 Insider transaction Dec 27, 2024 Dec 23, 2024
4 Insider transaction Dec 10, 2024 Dec 9, 2024
4 Insider transaction Dec 10, 2024 Dec 9, 2024
4 Insider transaction Dec 10, 2024 Dec 9, 2024
4 Insider transaction Dec 10, 2024 Dec 9, 2024
4 Insider transaction Dec 10, 2024 Dec 9, 2024
4 Insider transaction Dec 10, 2024 Dec 9, 2024
4 Insider transaction Dec 10, 2024 Dec 9, 2024
4 Insider transaction Dec 10, 2024 Dec 9, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
4 Insider transaction Sep 11, 2024 Sep 9, 2024
4 Insider transaction Sep 5, 2024 Sep 3, 2024
4 Insider transaction Sep 5, 2024 Sep 3, 2024
4 Insider transaction Jun 10, 2024 Jun 7, 2024
144 Notice of proposed sale Jun 7, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
4 Insider transaction Oct 30, 2023 Oct 26, 2023
4 Insider transaction Oct 30, 2023 Oct 26, 2023
4 Insider transaction Oct 30, 2023 Oct 26, 2023
4 Insider transaction Oct 30, 2023 Oct 26, 2023
4 Insider transaction Oct 30, 2023 Oct 26, 2023
4 Insider transaction Oct 30, 2023 Oct 26, 2023
4 Insider transaction Oct 30, 2023 Oct 26, 2023
4 Insider transaction Oct 30, 2023 Oct 26, 2023
3 Initial insider ownership Mar 7, 2023 Jan 1, 2023
3/A Ownership document Mar 7, 2023 Jan 1, 2023
3/A Ownership document Mar 7, 2023 Jan 1, 2023
3/A Ownership document Mar 7, 2023 Jan 1, 2023
3/A Ownership document Mar 7, 2023 Jan 1, 2023
SC 13G Ownership over 5% (passive) Mar 3, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
3 Initial insider ownership Jan 3, 2023 Jan 1, 2023
3 Initial insider ownership Jan 3, 2023 Jan 1, 2023
3 Initial insider ownership Jan 3, 2023 Jan 1, 2023
3 Initial insider ownership Jan 3, 2023 Jan 1, 2023
3 Initial insider ownership Jan 3, 2023 Jan 1, 2023
3 Initial insider ownership Jan 3, 2023 Jan 1, 2023
3 Initial insider ownership Jan 3, 2023 Jan 1, 2023
SC 13G Ownership over 5% (passive) Aug 12, 2022 —
SC 13G/A Amended ownership over 5% (passive) Mar 10, 2022 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2022 —
SC 13G Ownership over 5% (passive) Feb 10, 2022 —
SC 13G Ownership over 5% (passive) Nov 12, 2021 —
SC 13G/A Amended ownership over 5% (passive) Feb 16, 2021 —
SC 13G Ownership over 5% (passive) Jan 13, 2021 —
SC 13D/A Amended ownership over 5% (active) Apr 22, 2020 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2020 —
SC 13G Ownership over 5% (passive) Jan 17, 2020 —
SC 13G Ownership over 5% (passive) Jan 10, 2020 —
SC 13G/A Amended ownership over 5% (passive) Jan 3, 2020 —
SC 13D/A Amended ownership over 5% (active) Feb 20, 2019 —
SC 13G Ownership over 5% (passive) Feb 19, 2019 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2019 —
SC 13G Ownership over 5% (passive) Feb 12, 2019 —
SC 13G/A Amended ownership over 5% (passive) Jan 3, 2019 —
SC 13G/A Amended ownership over 5% (passive) Feb 20, 2018 —
SC 13G Ownership over 5% (passive) Feb 1, 2018 —
SC 13D Ownership over 5% (active) Aug 16, 2017 —
SC 13G Ownership over 5% (passive) May 9, 2017 —
SC 13G Ownership over 5% (passive) Mar 3, 2017 —
SC 13G Ownership over 5% (passive) Mar 3, 2017 —
SC 13G Ownership over 5% (passive) Feb 14, 2017 —

Showing 120 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
QNRX (Nasdaq)
Incorporated in
Israel
Headquarters
Ashburn, VA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1671502
Former names
Quoin Pharmaceuticals, Ltd. (until Sep 1, 2026); Cellect Biotechnology Ltd. (until Oct 15, 2021); Cellect Biomed Ltd. (until Jul 7, 2016)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.